A
Andrew G. Nicholson
Researcher at National Institutes of Health
Publications - 512
Citations - 87875
Andrew G. Nicholson is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Lung cancer & Idiopathic pulmonary fibrosis. The author has an hindex of 113, co-authored 477 publications receiving 73860 citations. Previous affiliations of Andrew G. Nicholson include National Yang-Ming University & University College London.
Papers
More filters
Journal ArticleDOI
The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification
Frank C. Detterbeck,Andrew G. Nicholson,Wilbur A. Franklin,Edith M. Marom,William D. Travis,Nicolas Girard,Douglas A. Arenberg,Vanessa Bolejack,Jessica S. Donington,Peter J. Mazzone,Lynn T. Tanoue,Valerie W. Rusch,John Crowley,Hisao Asamura,Ramón Rami-Porta +14 more
TL;DR: This work proposes to tailor TNM classification of multiple pulmonary sites of lung cancer to reflect the unique aspects of four different patterns of presentation, which will lead to more consistent classification and clarity in communication and facilitate further research in the nature and optimal treatment of these entities.
Journal ArticleDOI
An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study.
Simon L.F. Walsh,Athol U. Wells,Nicola Sverzellati,Gregory J. Keir,Lucio Calandriello,Katerina M. Antoniou,Susan J. Copley,A. Devaraj,Toby M. Maher,EA Renzoni,Andrew G. Nicholson,David M. Hansell +11 more
TL;DR: A clear prognostic separation of patients with pulmonary sarcoidosis is provided by a simple staging system integrating the composite physiological index (CPI) and two HRCT variables.
Journal ArticleDOI
The 8 th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications
TL;DR: This overview aims to provide radiologists with a description of the changes in the latest edition including staging of subsolid and multiple nodules, outline potential limitations of this 8th edition, as well as discussion on the implications on treatment.
Journal ArticleDOI
[The Masaoka-Koga stage classification for thymic malignancies clarification and definition of terms]
TL;DR: This article addresses the issue of consistency in terms of Masaoka and Koga classifications for thymic malignancies and hopes that this standard will be adopted by all researchers and will enhance collaboration and definition of a better classification system in the future.
Journal ArticleDOI
Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria.
Ganesh Raghu,Athol U. Wells,Andrew G. Nicholson,Luca Richeldi,Kevin R. Flaherty,Florence Le Maulf,Susanne Stowasser,Rozsa Schlenker-Herceg,David M. Hansell +8 more
TL;DR: Patients with IPF diagnosed in clinical practice who had possible UIP with traction bronchiectasis on HRCT and had not undergone surgical lung biopsy had disease that progressed in a similar way, and responded similarly to nintedanib, to that of patients with honeycombing onHRCT and/or confirmation of UIP by biopsy.